Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Some people have a short term focus, so yes, seeing last Q results not live up to their expectations can be negative. But, they didn't have bad results because no one wanted the product, they had bad results because they re-packaged their entire product line to go above and beyond the FDA's requirements.
If this next Q was bad, which for the record we know is not going to be bad, then I'd be concerned. Last Q is in the past, let's look forward now and the news/updates/changes on the horizon.
Watch and learn Elvis.
Regardless if KAVL dips, this line says a lot to me about the company we are invested in...
"It should be understood, that under no circumstance will Kaival Brands distribute, market, promote, or sell any product that would have deleterious consequences to the community and APPI guidelines – we have created a premium experience assisting current adult cigarette smokers age 21 and older to choose alternative options to traditional, combustible cigarettes. Kaival Brands will never behave in a manner that compromises health or the environment."
Hey fourcloze, we actually only did ~$10M revenue last quarter. The $65M is for the year.
The Company's fiscal fourth quarter saw a respite in revenue growth owed solely to Bidi Vapor's decision to do more than is required by the U.S. Food and Drug Administration's ("FDA") Premarket Tobacco Product Application (PMTA) standards with respect to packaging and labeling. While already well within federal standards, Bidi Vapor took additional action to go over and above the FDA's proposed guidelines. To that effect, Bidi Vapor halted production of all its products as it revamped the packaging and labeling of the entire product line, which, in turn, resulted in the Company being limited in the volume of products it could obtain from Bidi Vapor to distribute. Bidi Vapor incorporated suggestions from Kaival Brands' regulatory consultant, Blue Star Strategies, LLC, located in Washington D.C., and its dedicated FDA counsel, Keller and Heckman LLP, also located in Washington D.C., in revamping the packaging and labeling.
The revenue estimated were already mentioned for 2021, so I was really looking for this and I'm very happy with it...
Moreover, the company has executed the application for Kaival Brands shares to list on NASDAQ and anticipates the process to be completed in March.
I agree they should have said something, but water under the bridge at this point.
Other than that, I'm good with this!
Very nice!
Highest price since August!
Chart is breaking out perfectly.
We broke resistance, and then retested, count me in!
He doesn't own shares. He used to and bailed and haunts us with his bad decisions ever since.
Oh, Greg Arms is in charge of auditing the financials?
It's good to see that in 2021 they are still working together, I guess being a grey sheet doesn't concern them. Maybe Huggy should reach out to them lol.
Filing their annual by the extension deadline is not a great look?
Have to switch off that penny stock mentality or maybe we need to tell all these companies it's not smart to release earnings before a 3 day weekend...
https://markets.businessinsider.com/earnings-calendar#date=02/12/2021&name=&countries=&eventtypes=103,99&tab=ALL
Through our global network, our work spans over 6 continents where we support more than 2000 companies while offering services to over 4.5 million people and their families.
I disagree. As long as they file their annual by the extended deadline and avoid delinquency then we'll be fine.
As I've always said, and most importantly now, this isn't a short term "play". You are investing in a company that estimates $400M in revenue for the year, and just signed a huge new distribution deal.
If the estimate got us to this point, what do you think the real number shown in the quarterly/annual will do to the stock? It just bolsters the value further, plus any new products, new deals, new markets, etc.
Let's not waste our time and stress out over miniscule things like timing of filing or timing of PRs.
I guess understanding the difference between an assumption and a guarantee isn't as straight forward for some folks.
The 8K, the emails, etc have never used the word promise nor guarantee because SOLI/CareClix is not in charge of when their financials are completed, audited and signed off on.
There could be a million different reasons why things weren't completed in a timely manner but to me that's doesn't cast doubt on my personal findings as well as everything the board has provided.
You still haven't shown me where management promised anything.
I can't blame anyone for taking profits, especially those who have been here since a dime. I personally haven't sold any this run as I expect it to continue and not really in need of the $$.
This market, along with RLX, along with everything we're expecting, I can't see us staying down around $3 very long.
Quarterly Out!
Key takeaways:
Stockholder equity increased $7M q/q. Book value = $1.47
Revenue increased $10.5M
EPS for Q3 = .11
EPS for 9months = $.06
Crazy undervalued here!
I don't follow the lawyers, just the custodians.
I haven't sold a single share.
The upside potential here is massive. If we were just 1/10th the size of RLX (and our financials say we're much closer than that) we'd be trading over $12!
With the new distribution agreement that could double or triple our business? Why in the world would someone want to sell at $2 or $3. We could be at $20 sometime this year.
Not gonna happen yet, too much liquidity, low rates, more stimulus checks, etc. Drink the koolaid lol
Oh for sure, and it's all thanks to RLX's valuation.
Our day is coming, especially when we can get on NASD and get some institutional money flow.
This year should be great, that's why this dip today, and people selling clearly have no idea what they own.
I actually reached out to IR to clarify that point. No response yet but I'll share when I find out.
Think the extension puts us at Friday or sooner.
I think it was just panic, there was a suspension today, and the way things were running it was bound to set in at some point.
I don't think anything nefarious was going on, but who knows for sure, hope everyone picked up some cheapies!
Know what you own guys!
Custodians are an interesting breed haha. Just be ready for Elkonig coming around calling them illegally hijacked shells.
I owned some DIEN from Lazar, which he didn't R/S (yet) but after seeing the list of R/S he has done, I bailed for a decent profit.
With the way things are running PTAH looks good, just don't get stuck again.
Hate to break it to you Elvis, but it might not end like your experience has told you it would. You're going up against a completely different entity from all the others. Yes yes, you hear that all the time but the difference is CareClix. If you bothered to do any DD, or see what the board has uncovered and VERIFIED, you'll realize this doesn't stink like KMAG did, or DSUS or all those other turds.
I have no problem being wrong, and if the SEC puts the final nail in the coffin, I will king you the smarter man. BUT, when the financials are posted, well, I guess we'll discuss it at that time :)
KNC and David Lazar are both pretty lousy custodians compared to a few of the others out there.
Lazar is the reverse split king:
Blacklisting every single David Lazar shell. Risk of R/S$ANAS $CERPQ $CRGE $CXCQ $DIEN $EAIN $EENX $EXBX $FORU $FTGI $GLFW $GSHN $HKWO $IDAD $ILXP $INNX $ISRB $LGBI $NTAH $NXPC $OCBG $PFMS $QUTR $SBOX $SGLA $SHNL $SIPN $SOLS $TCPP $TTCS $USRI $VDPH $WDIS $XNNHQ $ZYRX
— OTC Chris (@otc_chris) June 5, 2020
Where? lol new 52w high again.
So obvious from the beginning.
Bidi is a private company, we have no insight into their financials.
KAVL is the exclusive distributor of Bidi products, we buy the product at discounted prices and sell them on a wholesale or retail basis. The difference in prices is our gross profit.
Bidi is doing great and providing us the cash flow/profits for future investments. KAVL has built a large distribution network of retailers and convenience stores, so any new products Bidi develops, or products that one of our subsidiaries develops, it can place it directly into that network quicker than it took Bidi to get up to speed.
Looking forward to the future here!
It's coming, trading right around 52w highs. Once it pops, it'll be very nice!
Lol!
SOLI will payoff for those who have patience. Until then, enjoy this hot market.
or end of week haha, two more 40% days and we're there.
Remember not too long ago we were talking about a small r/s to get onto NASD lol. At this point we won't need it.
KAVL has a very, VERY bright future. Even saying $10 or $15/share doesn't seem that out of whack anymore. At $15 that's only a $4B market cap.
RLX trades at $34B which would still give them an 8x higher valuation with maybe 4x the revenues?
I know we were all annoyed late last year when we were trading in the .30s and .40s, but I hope you guys took advantage.
That's a good post. Very clear and to the point.
Damnit bb, I thought we actually had news haha, wrong board.
Nothing wrong with waiting, and actually from my experience, the big pay days come from having patience.
That doesn't matter. Our valuation is based off of KAVL's distribution revenues. It's not valued on Patel's private company's asset.
Look at Elon Musk, he owns a few different companies, but none of them roll up into TSLA, because they are separate entities.
Jeff Bezos owns The Washington Post and Amazon. That doesn't mean AMZN owns The Washington Post, nor that the Washington Post's financials are included in Amazon's.
Completely different entities, with the same owner.
No Berdboy, Bidi Vapor is NOT owned by KAVL.
Yes, we are the exclusive distributors, but we do not OWN the asset and we do not manufacture the product. If we did, you'd see that show up on our balance sheet. Bidi Vapor's financials do not flow into KAVL, and vise versa, thus we are separate entities. No one else may ever sell Bidi products, but that still doesn't mean we own them.
No where in our filings would you see something like the below, because we are not one umbrella:
On September 28, 2020, Kaival Brands Innovations Group, Inc., a Delaware corporation (the “Company”), entered into a patent contribution agreement (the “Patent Contribution Agreement”) with Kaival Labs, Inc., a Delaware corporation and the Company’s wholly-owned subsidiary (“Kaival Labs”).